MTDX - Motion DNA Corporation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MTDX - Motion DNA Corporation

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: jmhollen	4/24/2006 11:38:51 AM
	of 3

Motion DNA Corp. releases year to date financials; Revenues increased through Q3-2005. Scottsdale, Arizona, October 14 2005--Motion DNA Corporation (OTC: MTDX.PK) has announced an increase in revenues for 2005. In 2004 the company generated just over $1.4 Million through the entire year, with the majority of the income produced in the final quarter of 2004. The company's assets currently total $1.2 million. The company is currently ahead of last year's annual revenue with just over $1.5 million in revenue through the first three quarters of 2005. Company officials expect to reach their revenue goals of $3M in revenue this year with launch of an intense marketing campaign and the majority of its revenue generating events scheduled for November and December. "We want to thank all of our shareholders for their patience in waiting for our financials," said Zig Ziegler, President of Motion DNA. "Our third quarter and fourth quarters are the biggest revenue generating periods for us and it was important to us to accurately depict the type of year we are having in 2005." About Motion DNA: Motion DNA Corporation provides diagnostic testing for medical professionals and sports organizations. Motion DNA's biomechanical analyses and detailed reports provide its customers and consumers with solutions for preventing injuries, identifying physical limitations, diagnosing preexisting injuries related to biomechanics, and improving physical performance levels. The company's technology will be available for sale beginning in December of 2005. For additional information on the company, please visit the company website at www.motiondnacorp.com. CONTACT INFORMATION Corporate Inquiries Mr. Zig Ziegler, President Telephone: 480-425-7734 Email: info@motiondnacorp.com Investor Relations AGORA Investor Relations agoracom.com MTDX@Agoracom.com SOURCE: Motion DNA Corp or Investors, AGORA Investor Relations, MTDX@Agoracom.com .

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next